^ 1.01.11.2Hirvonen E, Stenman UH, Mälkönen M, Rasi V, Vartiainen E, Ylöstalo P. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women. Maturitas. October 1988, 10 (3): 201–13. PMID 2972897. doi:10.1016/0378-5122(88)90023-0.
^ 2.02.1Husmann, Friedrich. Clinical Experiences with a Combination of Estradiol Valerate and Cyproterone Acetate for Hormone Replacement. Women's Health and Menopause. Medical Science Symposia Series 11. 1997: 257–261. ISBN 978-94-010-6343-2. ISSN 0928-9550. doi:10.1007/978-94-011-5560-1_38.
^ 3.03.1Schneider HP. Androgens and antiandrogens. Ann. N. Y. Acad. Sci. November 2003, 997 (1): 292–306. Bibcode:2003NYASA.997..292S. PMID 14644837. S2CID 8400556. doi:10.1196/annals.1290.033.
^Schneider HP. The role of antiandrogens in hormone replacement therapy. Climacteric. December 2000,. 3 Suppl 2: 21–7. PMID 11379383.
^ 5.05.1Fruzzetti F, Trémollieres F, Bitzer J. An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest. Gynecol Endocrinol. May 2012, 28 (5): 400–8. PMC 3399636. PMID 22468839. doi:10.3109/09513590.2012.662547.
^Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B. Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception. December 2011, 84 (6): 549–57. PMID 22078182. doi:10.1016/j.contraception.2011.04.009.
^Spona J, Schneider WH, Bieglmayer C, Schroeder R, Pirker R. Ovulation inhibition with different doses of levonorgestrel and other progestogens: clinical and experimental investigations. Acta Obstet Gynecol Scand Suppl. 1979, 88: 7–15. PMID 393050. S2CID 30486799. doi:10.3109/00016347909157223.
^Spona J, Huber J, Schmidt JB. Inhibierung der Ovulation mit 35 μg Athinylöstradiol und 2 mg Cyproteronazetat (Diane®-35) [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)]. Geburtshilfe Frauenheilkd. July 1986, 46 (7): 435–8. PMID 3093307. doi:10.1055/s-2008-1026659(German). 引文格式1维护:未识别语文类型 (link)
^Spona J, Huber J. Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate. Gynecol Obstet Invest. 1987, 23 (3): 184–93. PMID 2954886. doi:10.1159/000298860.
^Spona, J.; Huber, J.; Schmidt, J. B. Ovulation inhibitory effect of SH B 209 AE (Diane-35)—a new antiandrogen-estrogen combination. Schindler, Adolf E. (编). Antiandrogen-Estrogen Therapy for Signs of Androgenization. Berlin, Boston: De Gruyter. 1987-12-31: 51–58. ISBN 9783110866902. doi:10.1515/9783110866902-006.
^Hammerstein, J. Antiandrogens: Clinical Aspects. Hair and Hair Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg. 1990: 827–886. ISBN 978-3-642-74614-7. doi:10.1007/978-3-642-74612-3_35.
^Hirvonen E, Allonen H, Anttila M, Kulmala Y, Ranta T, Rautiainen H, Sipilä P, Ylöstalo P. Oral contraceptive containing natural estradiol for premenopausal women. Maturitas. January 1995, 21 (1): 27–32. PMID 7731379. doi:10.1016/0378-5122(94)00856-3.
戊酸雌二醇, 醋酸环丙孕酮, 维基百科中的醫學内容仅供参考, 並不能視作專業意見, 如需獲取醫療幫助或意見, 请咨询专业人士, 詳見醫學聲明, 英語, estradiol, valerate, cyproterone, acetate, 简称, 以克龄蒙, 英語, climen, 和femilar等品牌销售, 是戊酸雌二醇, 一种雌激素, 和醋酸环丙孕酮, 一种孕激素, 的组合产品, 用于绝经期激素治疗和作为妇女避孕药使用, 其为口服药, 克龄蒙用于绝经期激素治疗, 是一种序贯制剂, 含有2毫克ev和1毫克cpa,. 维基百科中的醫學内容仅供参考 並不能視作專業意見 如需獲取醫療幫助或意見 请咨询专业人士 詳見醫學聲明 戊酸雌二醇 醋酸环丙孕酮 英語 Estradiol valerate cyproterone acetate 简称 EV CPA 以克龄蒙 英語 Climen 和Femilar等品牌销售 是戊酸雌二醇 EV 一种雌激素 和醋酸环丙孕酮 CPA 一种孕激素 的组合产品 用于绝经期激素治疗和作为妇女避孕药使用 1 其为口服药 1 克龄蒙用于绝经期激素治疗 是一种序贯制剂 含有2毫克EV和1毫克CPA 2 3 4 它是第一个上市的用于绝经期激素治疗的含有CPA的产品 3 在40多个国家有售 2 Femilar是一种含雌二醇的避孕药 含有1至2毫克EV和1至2毫克CPA 自1993年以来在芬兰被批准使用 5 戊酸雌二醇 醋酸环丙孕酮戊酸雌二醇 顶部 和醋酸环丙孕酮 下 组成戊酸雌二醇雌激素醋酸环丙孕酮孕激素臨床資料商品名 英语 Drug nomenclature 克龄蒙 Climen Femilar其他名稱EV CPA给药途径口服藥物類別 英语 Drug class 雌激素 孕激素法律規範狀態法律規範美 处方药 only 识别信息CAS号108116 22 9一项研究发现 单用CPA在0 5毫克 天的剂量下 5名妇女中有3名抑制排卵 在1毫克 天的剂量下 5名妇女中有5名抑制排卵 6 7 8 9 10 11 在一项研究中 108名妇女中有94 4 在第三个治疗周期内发生Femilar的排卵抑制 在另一项研究中 26名妇女在12个治疗周期内几乎100 发生排卵抑制 除了一名妇女在第一个治疗周期内排了卵 5 12 1 参考文献 编辑 1 0 1 1 1 2 Hirvonen E Stenman UH Malkonen M Rasi V Vartiainen E Ylostalo P New natural oestradiol cyproterone acetate oral contraceptive for pre menopausal women Maturitas October 1988 10 3 201 13 PMID 2972897 doi 10 1016 0378 5122 88 90023 0 2 0 2 1 Husmann Friedrich Clinical Experiences with a Combination of Estradiol Valerate and Cyproterone Acetate for Hormone Replacement Women s Health and Menopause Medical Science Symposia Series 11 1997 257 261 ISBN 978 94 010 6343 2 ISSN 0928 9550 doi 10 1007 978 94 011 5560 1 38 3 0 3 1 Schneider HP Androgens and antiandrogens Ann N Y Acad Sci November 2003 997 1 292 306 Bibcode 2003NYASA 997 292S PMID 14644837 S2CID 8400556 doi 10 1196 annals 1290 033 Schneider HP The role of antiandrogens in hormone replacement therapy Climacteric December 2000 3 Suppl 2 21 7 PMID 11379383 5 0 5 1 Fruzzetti F Tremollieres F Bitzer J An overview of the development of combined oral contraceptives containing estradiol focus on estradiol valerate dienogest Gynecol Endocrinol May 2012 28 5 400 8 PMC 3399636 PMID 22468839 doi 10 3109 09513590 2012 662547 Endrikat J Gerlinger C Richard S Rosenbaum P Dusterberg B Ovulation inhibition doses of progestins a systematic review of the available literature and of marketed preparations worldwide Contraception December 2011 84 6 549 57 PMID 22078182 doi 10 1016 j contraception 2011 04 009 Spona J Schneider WH Bieglmayer C Schroeder R Pirker R Ovulation inhibition with different doses of levonorgestrel and other progestogens clinical and experimental investigations Acta Obstet Gynecol Scand Suppl 1979 88 7 15 PMID 393050 S2CID 30486799 doi 10 3109 00016347909157223 Spona J Huber J Schmidt JB Inhibierung der Ovulation mit 35 mg Athinylostradiol und 2 mg Cyproteronazetat Diane 35 Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate Diane 35 Geburtshilfe Frauenheilkd July 1986 46 7 435 8 PMID 3093307 doi 10 1055 s 2008 1026659 German 引文格式1维护 未识别语文类型 link Spona J Huber J Efficacy of low dose oral contraceptives containing levonorgestrel gestoden and cyproterone acetate Gynecol Obstet Invest 1987 23 3 184 93 PMID 2954886 doi 10 1159 000298860 Spona J Huber J Schmidt J B Ovulation inhibitory effect of SH B 209 AE Diane 35 a new antiandrogen estrogen combination Schindler Adolf E 编 Antiandrogen Estrogen Therapy for Signs of Androgenization Berlin Boston De Gruyter 1987 12 31 51 58 ISBN 9783110866902 doi 10 1515 9783110866902 006 Hammerstein J Antiandrogens Clinical Aspects Hair and Hair Diseases Berlin Heidelberg Springer Berlin Heidelberg 1990 827 886 ISBN 978 3 642 74614 7 doi 10 1007 978 3 642 74612 3 35 Hirvonen E Allonen H Anttila M Kulmala Y Ranta T Rautiainen H Sipila P Ylostalo P Oral contraceptive containing natural estradiol for premenopausal women Maturitas January 1995 21 1 27 32 PMID 7731379 doi 10 1016 0378 5122 94 00856 3 外部連結 编辑戊酸雌二醇片 补佳乐 克龄蒙 MtF wiki 页面存档备份 存于互联网档案馆 简体中文 这是一篇关于类固醇的小作品 你可以通过编辑或修订扩充其内容 查论编 取自 https zh wikipedia org w index php title 戊酸雌二醇 醋酸环丙孕酮 amp oldid 77428281, 维基百科,wiki,书籍,书籍,图书馆,